Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis

C Chen, MP Douglas, MV Ragavan, KA Phillips… - Molecular Diagnosis & …, 2024 - Springer
Abstract Purpose Circulating tumor DNA (ctDNA) testing has become a promising tool to
guide first-line (1L) targeted treatment for advanced non-small cell lung cancer (aNSCLC) …

Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC)

AV Ospina - Clinical Oncology, 2024 - Elsevier
Solid tumour tissue has traditionally been used for cancer molecular diagnostics. Recently,
biomarker assessment in blood or liquid biopsies has become relevant because it allows …

Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated …

K Kunimasa, K Nishino, Y Sato, M Mori, S Ihara… - Scientific Reports, 2022 - nature.com
Circulating tumor DNA (ctDNA)-based next-generation sequencing (NGS) is a
complementary and alternative test to tissue-based NGS. We performed NGS analysis of …

Comprehensive molecular profiling identifies actionable biomarkers for patients from Thailand and the United Arab Emirates with advanced malignancies

S Dawood, V Natarajan, P Danchaivijitr - Frontiers in Oncology, 2024 - frontiersin.org
Background: Comprehensive molecular profiling of tissue samples that can help guide
therapy management is not widely available across the globe. Methods: Comprehensive …

Interaction Between Genetic Susceptibility and COVID-19 Pathogenesis in Pediatric Multisystem Inflammatory Disorders: The Role of Immune Responses

LN Chen, ZX Shou, X Jin - Viral Immunology, 2024 - liebertpub.com
Numerous studies have highlighted the emergence of coronavirus disease (COVID-19)
symptoms reminiscent of Kawasaki disease in children, including fever, heightened …

[PDF][PDF] An overview of comprehensive genomic profiling technologies to inform cancer care

S Basharat, K Farah - Canadian Journal of Health …, 2022 - canjhealthtechnol.ca
Purpose The purpose of this Horizon Scan is to present health care stakeholders in Canada
with an overview of information related to liquid biopsy–based comprehensive genomic …

Rôle des médecins dans l'adhésion des patients et des familles à la réalisation d'analyses de caractéristiques génétiques

E Chipoulet, G Collet, B Couderc - Bulletin du Cancer, 2023 - Elsevier
Résumé Introduction En oncologie et dans le cadre du développement des thérapies
ciblées, de plus en plus de patients atteints de cancer se voient proposer par leur médecin …

[HTML][HTML] CADTH Horizon Scan An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Care

S Basharat, K Farah, J Horton - canjhealthtechnol.ca
Purpose The purpose of this Horizon Scan is to present health care stakeholders in Canada
with an overview of information related to liquid biopsy–based comprehensive genomic …

[引用][C] Kei Kunimasa1, 8Ε, Kazumi Nishino1, 8, Yoshiharu Sato2, Masahide Mori3, Shoichi Ihara4, Hidekazu Suzuki5, Izumi Nagatomo6, Toru Kumagai1, Toshitaka …

F Imamura - Scientific Reports, 2022